Doxorubicin-loaded erythrocytes (DLE) were administrated to 15 lymphoma patients. Antibiotic peak concentration in blood decreased by 55%, doxorubicin circulated several times longer, and the area under the concentration-time curve increased 5 times if compared with standard doxorubicin administration. The DLE was well tolerated by patients.

Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes

Skorokhod, Oleksii
;
2007-01-01

Abstract

Doxorubicin-loaded erythrocytes (DLE) were administrated to 15 lymphoma patients. Antibiotic peak concentration in blood decreased by 55%, doxorubicin circulated several times longer, and the area under the concentration-time curve increased 5 times if compared with standard doxorubicin administration. The DLE was well tolerated by patients.
2007
92
4
570
571
doxorubicin; carrier erythrocytes; pharmacokinetics; lymphoma
Skorokhod, Oleksii; Kulikova, Elena V; Galkina, Ninel M; Medvedev, Pavel V; Zybunova, Elena E; Vitvitsky, Victor M; Pivnik, Aleksandr V; Ataullakhanov...espandi
File in questo prodotto:
File Dimensione Formato  
Skorokhod et al - Doxo pharmacokin - Haematol 2007.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 90.69 kB
Formato Adobe PDF
90.69 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1892242
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 28
social impact